|1.||Song, Geum-Ju: 1 article (05/2013)|
|2.||Hunsinger, Hans: 1 article (05/2013)|
|3.||Seok, Kwang-Seol: 1 article (05/2013)|
|4.||Kim, Sam-Cwan: 1 article (05/2013)|
|5.||Ko, Yun-Hwa: 1 article (05/2013)|
|6.||Humar, Bostjan: 1 article (06/2008)|
|7.||Reeve, Anthony E: 1 article (06/2008)|
|8.||Dunbier, Anita: 1 article (06/2008)|
|9.||Heathcott, Rosemary: 1 article (06/2008)|
|10.||McNoe, Les: 1 article (06/2008)|
05/01/2003 - "When administered during the first steps of the infection, APHS was capable of inhibiting the replication of several HIV-1 strains (macrophage-tropic and/or lymphocytotropic) in a dose-dependent manner in both peripheral blood mononuclear cells (PBMC), monocyte-derived macrophages and peripheral blood lymphocytes with 50% inhibitory concentration values of approximately 10 microM. "
03/01/1995 - "The APHS vaccine, studied through challenge infection of vaccinated rabbits (post-60 days of vaccination), showed 100% potency when stored at 4 degrees C for 30 days. "
05/01/2003 - "APHS also did not inhibit HIV-1 entry into the host cells as determined by quantification of gag RNA inside PBMC 2h after infection. "
|3.||Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
|4.||Colorectal Neoplasms (Colorectal Cancer)
|2.||RNA (Ribonucleic Acid)
|3.||Aspirin (Acetylsalicylic Acid)
|4.||aluminum sulfate (alum)